Project Grant R35GM163713
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded UC Berkeley $119,907 under the Biomedical Research and Research Training program (CFDA 93.859) for a two-year project period (August 1, 2025 – July 31, 2027). This Project Grant funds fundamental research to advance understanding of TnpB, a compact transposon-encoded RNA-guided endonuclease with significant potential for genome-editing applications. The research delivers three primary products: (1) a...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Regents of the University of California, doing business as University of California, Berkeley, a Project Grant totaling $361,952 under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, with a completion date of June 30, 2030. This award funds fundamental research aimed at mapping and predicting the sequence-function landscape of biomedically...
- Federal Project Grant Award Summary The University of California, Berkeley, received a $152,300 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through February 28, 2029. The Nogales Lab will conduct fundamental research to elucidate molecular mechanisms of gene regulation by investigating how regulatory proteins modulate Transcription Factor IID (TFIID), a...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant totaling $415,252 to the University of California, Berkeley, effective July 1, 2025 through June 30, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports fundamental research investigating the physical biology of transcriptional control in embryonic development, specifically focusing on predictive modeling of gene expression...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, Berkeley a Project Grant totaling $441,375 under the Biomedical Research and Research Training program (CFDA 93.859) effective April 1, 2026 through March 31, 2031. The award funds fundamental research investigating the cellular and developmental mechanisms by which animals respond to intracellular beneficial microorganisms. The research utilizes the small sea...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded UC Berkeley $617,574 under the Biomedical Research and Research Training program (CFDA 93.859) for fundamental research into site-specific non-LTR retrotransposon mechanisms of mobility and transgene insertion. The project, active from March 9, 2026 through February 28, 2030, supports investigation of how non-LTR retrotransposon reverse transcriptases insert DNA sequences into animal genomes, with...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded UC Berkeley $387,596 under the Biomedical Research and Research Training program (CFDA 93.859) on June 1, 2026, for a project titled "Engineering Specialized Organelles in Yeast for Compartmentalized Production of Therapeutics." The award supports fundamental research to re-engineer peroxisomes and vacuoles as synthetic, specialized organelles capable of compartmentalizing metabolic...
- Federal Grant Award Summary The University of California, Irvine received a $384,527 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award funds research to decipher the interactome and biological functions of disordered microproteins—a recently identified class of proteins composed of fewer than 100-150 amino acids encoded by small open...
- Federal Project Grant Award Summary The University of California, Merced received a $400,910 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to conduct computational modeling research on RNA Polymerase II (Pol II) elongation complexes. The award, effective June 1, 2026, through March 31, 2031, supports fundamental research using molecular dynamics simulations and advanced computational...
- Federal Grant Award Summary The National Institute of General Medical Sciences awarded UC Berkeley a $226,560 Project Grant effective March 1, 2026, through December 30, 2028, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of new catalytic methods and modular synthesis approaches for creating saturated, nitrogen-containing heterocyclic building blocks—critical pharmaceutical precursors currently underrepresented in commercial...
The University of California, Berkeley received a $246,263 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2026 through June 30, 2031. This award supports fundamental biomedical research investigating post-transcriptional regulatory networks and the Integrated Stress Response (ISR) pathway. The research will comprehensively map cofactors engaged by regulatory RNA-binding proteins and systematically perturb regulatory connections to understand how ISR dynamics control cellular responses to stress and environmental challenges. Through high-throughput measurement of thousands of designed variants across multiple conditions, the project will elucidate the complex feedback mechanisms that govern stress response dynamics and their protective or pathogenic roles in cellular physiology. The funded research addresses critical gaps in understanding how cells rapidly modulate translation and transcript degradation to regulate protein synthesis in response to proteostasis challenges. By quantitatively characterizing the regulatory networks underlying post-transcriptional gene expression control, this work will establish foundational knowledge applicable to both normal cellular adaptation and disease phenotypes where stress response dysregulation contributes to pathology. The project integrates systems-level analysis with targeted experimental perturbations to deliver insights into how intrinsically disordered regions within regulatory proteins coordinate with core cellular factors to control adaptive cellular behaviors.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $246.3k | 6/1/26 |